Literature DB >> 9585608

Evidence of founder mutations in Finnish BRCA1 and BRCA2 families.

P Huusko, K Pääkkönen, V Launonen, M Pöyhönen, G Blanco, A Kauppila, U Puistola, H Kiviniemi, M Kujala, J Leisti, R Winqvist.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9585608      PMCID: PMC1377159          DOI: 10.1086/301880

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


× No keyword cloud information.
  20 in total

Review 1.  Impact of germline and somatic BRCA1/2 mutations: tumor spectrum and detection platforms.

Authors:  H Wu; X Wu; Z Liang
Journal:  Gene Ther       Date:  2017-08-03       Impact factor: 5.250

Review 2.  Mutations in context: implications of BRCA testing in diverse populations.

Authors:  Gabriela E S Felix; Yonglan Zheng; Olufunmilayo I Olopade
Journal:  Fam Cancer       Date:  2018-10       Impact factor: 2.375

3.  Haplotypes of the I157T CHEK2 germline mutation in ethnically diverse populations.

Authors:  Bella Kaufman; Yael Laitman; Jacek Gronwald; Robert Winqvist; Arvids Irmejs; Jan Lubinski; Katri Pylkäs; Janis Gardovskis; Edvins Miklasevics; Eitan Friedman
Journal:  Fam Cancer       Date:  2009-07-17       Impact factor: 2.375

4.  Mutation analysis of the AATF gene in breast cancer families.

Authors:  Maria Haanpää; Mervi Reiman; Jenni Nikkilä; Hannele Erkko; Katri Pylkäs; Robert Winqvist
Journal:  BMC Cancer       Date:  2009-12-21       Impact factor: 4.430

5.  Familial breast cancer screening reveals an alteration in the RAP80 UIM domain that impairs DNA damage response function.

Authors:  J Nikkilä; K A Coleman; D Morrissey; K Pylkäs; H Erkko; T E Messick; S-M Karppinen; A Amelina; R Winqvist; R A Greenberg
Journal:  Oncogene       Date:  2009-03-23       Impact factor: 9.867

6.  BRCA2 mutations in 154 finnish male breast cancer patients.

Authors:  Kirsi Syrjäkoski; Tuula Kuukasjärvi; Kati Waltering; Karin Haraldsson; Anssi Auvinen; Ake Borg; Tommi Kainu; Olli-P Kallioniemi; Pasi A Koivisto
Journal:  Neoplasia       Date:  2004 Sep-Oct       Impact factor: 5.715

Review 7.  Pathology of hereditary breast cancer.

Authors:  Petra van der Groep; Elsken van der Wall; Paul J van Diest
Journal:  Cell Oncol (Dordr)       Date:  2011-02-19       Impact factor: 6.730

Review 8.  Founder populations and their uses for breast cancer genetics.

Authors:  S L Neuhausen
Journal:  Breast Cancer Res       Date:  2000-02-07       Impact factor: 6.466

9.  Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control.

Authors:  Ramūnas Janavičius
Journal:  EPMA J       Date:  2010-06-27       Impact factor: 6.543

10.  Multiplex SNaPshot for detection of BRCA1/2 common mutations in Spanish and Spanish related breast/ovarian cancer families.

Authors:  Sandra Filippini; Ana Blanco; Ana Fernández-Marmiesse; Vanesa Alvarez-Iglesias; Clara Ruíz-Ponte; Angel Carracedo; Ana Vega
Journal:  BMC Med Genet       Date:  2007-06-29       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.